Lowenthal Richard E (CIK 0001378550)

Latest company ownership

Shares held
82,733
Last filed at
Nov 10, 2022
Confidence Score
49.7
2025Q4
Confidence Score History
2024Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Aug 21, 2025 Aug 22, 2025 ARS Pharmaceuticals, Inc. CEO Sell 46.3 -50,000 -0.44% ✓ $724.3K
Dec 17, 2024 Dec 19, 2024 ARS Pharmaceuticals, Inc. CEO Sell 42.5 -100,000 -0.87% ✓ $1.2M
Dec 10, 2024 Dec 11, 2024 ARS Pharmaceuticals, Inc. CEO Sell 42.5 -100,000 -0.86% ✓ $1.3M
Nov 19, 2024 Nov 21, 2024 ARS Pharmaceuticals, Inc. CEO Sell 42.5 -100,000 -0.86% ✓ $1.4M
Nov 12, 2024 Nov 14, 2024 ARS Pharmaceuticals, Inc. CEO Sell 42.5 -100,000 -0.85% ✓ $1.7M
Oct 15, 2024 Oct 17, 2024 ARS Pharmaceuticals, Inc. CEO Sell 42.5 -100,000 -0.84% ✓ $1.5M
Oct 8, 2024 Oct 10, 2024 ARS Pharmaceuticals, Inc. CEO Sell 42.5 -100,000 -0.84% ✓ $1.4M
Sep 17, 2024 Sep 19, 2024 ARS Pharmaceuticals, Inc. CEO Sell 42.5 -100,000 -0.83% ✓ $1.3M
Sep 10, 2024 Sep 12, 2024 ARS Pharmaceuticals, Inc. CEO Sell 42.5 -100,000 -0.82% ✓ $1.1M
Aug 20, 2024 Aug 21, 2024 ARS Pharmaceuticals, Inc. CEO Sell 42.5 -100,000 -0.82% ✓ $1.5M
Aug 13, 2024 Aug 15, 2024 ARS Pharmaceuticals, Inc. CEO Sell 42.5 -100,000 -0.81% ✓ $1.2M
Jul 16, 2024 Jul 18, 2024 ARS Pharmaceuticals, Inc. CEO Sell 42.5 -100,000 -0.80% ✓ $1.1M
Jul 9, 2024 Jul 11, 2024 ARS Pharmaceuticals, Inc. CEO Sell 45.0 -100,000 -0.80% ✓ $961.7K
Jun 11, 2024 Jun 13, 2024 ARS Pharmaceuticals, Inc. CEO Sell 45.0 -100,000 -0.79% ✓ $913.9K
May 14, 2024 May 16, 2024 ARS Pharmaceuticals, Inc. CEO Sell 45.0 -100,000 -0.62% ✓ $905.4K
May 7, 2024 May 9, 2024 ARS Pharmaceuticals, Inc. CEO Sell 45.0 -100,000 -0.78% ✓ $934.4K
Apr 16, 2024 Apr 17, 2024 ARS Pharmaceuticals, Inc. CEO Sell 45.0 -100,000 -0.79% ✓ $928K
Apr 9, 2024 Apr 10, 2024 ARS Pharmaceuticals, Inc. CEO Sell 45.0 -100,000 -0.78% ✓ $927.7K
Mar 22, 2024 Mar 26, 2024 ARS Pharmaceuticals, Inc. CEO Sell 45.0 -97,610 -0.76% ✓ $890.3K
Mar 19, 2024 Mar 21, 2024 ARS Pharmaceuticals, Inc. CEO Sell 57.5 -2,390 -0.02% ✓ $21.6K
Mar 13, 2024 Mar 15, 2024 ARS Pharmaceuticals, Inc. CEO Sell 45.0 -100,000 -0.77% ✓ $913.7K
Feb 29, 2024 Mar 1, 2024 ARS Pharmaceuticals, Inc. CEO Sell 57.5 -3,782 -0.03% ✓ $34.1K
Feb 26, 2024 Feb 28, 2024 ARS Pharmaceuticals, Inc. CEO Sell 45.0 -99,478 -0.67% ✓ $897.4K